ReviewFrontiers in endocrinology2020

Clinical Evidence for the Benefits of Burosumab Therapy for X-Linked Hypophosphatemia (XLH) and Other Conditions in Adults and Children.

Aaron Schindeler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.